The Risk of Genetic Polymorphisms in the Immune Genes on the Developed of Respiratory Allergic Diseases
Israa Hussein Hamzah, Noor Al-Huda Ali A. H. Saeed, Alaa N Mohammed Ali
College of Science, Mustansiriyah University, Baghdad, Iraq.
*Corresponding Author E-mail: szsh@uomustansiriyah.edu.iq; esraahussan17@gmail.com
ABSTRACT:
Allergic diseases are intricate and improvement includes both natural and hereditary components. besides classic Tcell-originated T helper form-2 cytokine comparable to IL4; IL5; IL13. Tissues created cytokine akin to thymic-stromal-lymphopoietin. IL25 as well as IL33 at the moment is famous the main contribution of allergies irritation. IL33 generated via quite a lot of tissue living cells and generally enhances allergic infection using its results in hematopoietic-cells varieties. Ecological and endogenously triggered which induce IL33 cell released could also correlated to contamination, irritation and tissues harm. Current review brief an extensive variety for certified IL33 efficiency in human-cellular-mediatory in irritation like good as genetically marker when IL33 contributed with sickness. At last, IL33 attached with IL1/RL1 was engaged with asthma. previous information shows in some investigation that contribution by IL33-IL1RL1 gene with asthma was biologically conceivable, IL33 on asthma patients can influence expressing levels for IL33 serum. Moreover, rs16924159/G-A variation is related in IL33 level of respiratory hypersensitive diseases patients.
KEYWORDS: Allergy, Polymorphism, IL33, Respiratory diseases, Iraq.
INTRODUCTION:
Allergy is an immune system response to harmless natural antigens, intervened via immunoglobulins-E antibody. in definitional, it is a basic reason for whole allergies diseases, for example, asthma, hypersensitivity rhinitis. Hypersensitivity diseases are perplexing and improvement includes both natural and hereditary factors1.
Developmental of allergies is perplexing but not-completely comprehended, in each ecological or hereditary part. Ecological alterations were a concept that added to expanded rate for hypersensitivity lately with proof of part from tobacco-smoker presentation, respiratory-viral diseases, utilization in anti-microbial, introduction of allergies for give some examples2,3,4.
Asthma is the persistent lungs disease in which arouses as well as narrows an airway. It is causes repeated time in wheeziness, chest-snuggle, windedness, coughing. Coughing much happens around evening-time or immediately in a first part of day. Asthma impacts peoples of all ages, frequently initiate during childhood3.
Genes associated with both innate and adaptive immune responses have been distinguished, quite incorporating various genes associated with epithelial capacity/secretion, recommending that airways epithelial can especially significant on asthma, Gene recognizable proof will change the comprehension in malady instruments or produce likely curative chances. Despite pattern-recognition-receptor (PRR); transcriptional factor; chemokines while cytokines all assume basic functions on organizing immune-system or the expressing/activating which directly connect with human ailment resilience. Besides, genetically varieties present on immune-responses gene in different nationalities that clarify colossal contrasts on singular results of different illnesses also follow the exposition to infections elements.
Primarily natural appearance of inflammatory is enlistment of immune-cells. The cycle organized via cytokine and chemokine, a basic modulatory in acute or chronic inflammatory. Around 100 cytokine depicted today with changed capacities and strain. Cytokine maybe pro-anti inflammation/ mitogen/ hematopoietic as well as chemo tactic, assume significant part on controlled whole periods on inflammation reactions. In present review, we exhibiting relationship of cytokine and chemokine genes variations with hypersensitivity respiratory infection like asthma. There are distinctive variation genes that have connection with disease… we will feature on interleukin - 33 and its part on improvement of hypersensitivity maladies.
Interleukin33 (IL33):
It belonged to a bigger family of harm related sub-atomic type particles, it is considered as 'alarmin', delivered to alarm an immune-system via first line-cells, for example, tissue-epithelium-cells, follow presentation for exogenously improvements, included allergen7,8. IL-33 plays significant functions in allergic diseases predominantly by teaching the efficiency of different ST2-expression cells and the creation of a few resistant variables. The components hidden IL33 mediate irritation that immunological analyzing. Nonetheless, more stay to lit up for the exact capacities and hidden systems of the IL-33-ST2 signaling pathways in these hypersensitive diseases9.
Genetically link synthetic among asthma and sensitivity correlated attributes or polymorphism of gene encoded IL33 also ST2 (IL1RL1) Polymorphism on IL-33 genes
-chromosome 9q- which related in Japanese-cedar-pollinosis, more widely recognized type of allergy at Japan10.
Allergic airway diseases:
Asthma and allergic rhinitis are basic chronic infections of the respiratory tract. The two conditions regularly exist together and show fundamental appearances including atopy and blood eosinophilia11. Allergic rhinitis and asthma beset roughly 25% of people in developed countries. In allergic subjects steady or dreary exposure to allergens which ordinarily are naturally harmless substances normal in the earth, brings about incessant hypersensitive irritation12,13. Albeit extreme or dangerous in just a minority, hypersensitive aviation routes sickness influences the nature of day-by-day life of numerous patients with sway on school participation and profitability at work14,15.
The biology role of interleukin-33:
Interleukin - 33 (IL-33), the most recent individual from the IL-1 family, is a ligand for ST2 (otherwise called IL1RL) and offer a signaling pathway with IL-1 and IL-1816. IL33 attached to their receptors to prompt type-2 cytokine also apply each pro inflammation and protection role on host defenses or diseases17.
It is considered to work as a disturbing or risk cytokine that is delivered upon basic cell damage. This cytokine actuates a few insusceptible cell, for example, Th2 cells, mast cells and basophils, following its connection with a cell surface receptor ST2, this initiation prompts the creation of an assortment of Th2-like cytokines that intervened unfavorably susceptible sort resistant reaction18,19. Subsequently, IL-33 has been studied basically for its role with regards to Th2 related diseases, for example, asthma, atopic dermatitis and hypersensitivity20. IL-33 animates both innate and acquired hypersensitivity related cells to instigate and enlarge Th2 cytokine creation, which lead to eosinophilic irritation in vivo16. In hypersensitive maladies IL-33 adjusts bond, initiation, development and cytokine creation by mast cells21.
Likewise IL33 delivered on extra cellular area next cells destroy (necrotizing cell demise) and mechanistic injure, accordingly proposer of work like novel caution (intra-cellular caution sign delivered to cells injure for alarm the immune-system on tissues harm follows injury and disease22. For a long time, IL-33 has been broadly concentrated with regards to Th2 driven provocative issues. Presently, IL-33 has developed as a cytokine with plenty or pleiotropic properties relying upon the resistant cells focused by IL-33, it is accounted for to advance Th2 immunity as well as to induce Th1 immunity23.
IL33 roles on airway diseases:
Interleukin-33 a cytokine that has key functions in the acceptance and propagation of allergic aggravation, it is emphatically communicated via aviation route epithelial cells24. Accordingly, IL-33 is by all accounts a helpful marker of Th2 intervened malady including allergic rhinitis and bronchial asthma, it is delivered by epithelial cells when they become harmed or advancing the seriousness of sensitivities25.
This cytokine could be seen as a marker for tissue hurt, especially in epithelium of cell while it becomes injury and necrosis. Recently considers have ensnared a position in IL33 at the pathogenic on respiratory hypersensitivity and asthma26,27. Exogenously articulation of IL33 at antigens guileless mouse which prompts the common Th-2 reaction as well as key asthma qualities included type-2 cytokines/IgE product, aviation route irritation, mucous secreting, eosinophilic and aviation route hyper reaction on antigens-reliant or freeway28,29. It was demonstrated that IL-33 could drive allergy and asthma pathogenesis by interaction with both innate and adaptive immune system26.
In asthma, introduction to airborne allergens, contamination, respiratory infections made harm the pneumonic epithelia and/or actuation of example acknowledgment receptor, for example, TLRs prompting arrival on IL33 of lungs structure cell, like epithelium, IL33 driven allergies refinement using impacts on aviation route dendritic-cell or advancement in Th-2 interceded pathological through an age of IL4, IL5, IL-13. IL33 prompts generation of macrophage then again initiation phenotype and to the enrollment development and endurance of eosinophil, as appeared in Figure (1)30.
As reportedly, each IL-33 and ST-2 polymorphism are firmly connected to asthma and sensitivity powerlessness in humans, recommending IL-33 systems maybe new therapies targeting31,32.
Genetic polymorphism of IL-33 levels in cases are found in specific patients with rhinitis, conjunctivitis and rhinosinusitis33,34. In ragweed dust initiated hypersensitive rhinitis, IL-33 improve arrival of histamine and chemo-attractant factors for eosinophils and basophils by mast cells and basophils, adding to neighborhood irritation in beginning stage (sneezing) and late-stage (nasal amassing of eosinophils and basophils) of disease as appeared in Figure (2)35.
Figure 1: IL-33 in allergic asthma
Figure 2: IL-33 in allergic rhinitis
Numerous investigations have ensnared the function of IL-33 in the pathogenesis of respiratory hypersensitivity and asthma26. IL-33 has been distinguished like trigger on T-helper2 cells separation, when via collaborating of each innate and adaptive immune-system drive sensitivity or asthma pathogenic25.
There is a noteworthy ascent in sera level of IL33 in an asthmatic patient, this concurrence by a study done in Egypt35, they found that IL33 and receptor ST-2 are uniquely raised in bronchial asthma patients. There is numerous information suggesting that IL-33 can engaged with lung irritation36 acquired end bronchial biopsies from grown-ups with mellow, moderate and severe asthma, they found that airway smooth muscle cells from asthmatic paying little mind to seriousness of infection, communicated expanded IL-33 mRNA levels contrasted and controls. IL-33 protein was prevalently communicated via aviation route smooth muscle cells, epithelial and endothelial cells in asthmatic lung however were missing in charge gatherings and this expansion emphatically connects with asthma seriousness37,38 indicated expanded sera IL33 level of asthma patients than of non-unfavorably susceptible control and infer that IL33 a marker for asthma seriousness, also add to air-way redesigning on asthma via following up of human lungs fibroblast.
IL-33 considers assuming the vital function on allergy-inflammation diseases, for example, rhinitis. The late examination with respect to the IL33/ST-2 axis contributes to Th-2 inflammation reactivity and rhinitis pathogenic.
Study34 demonstrating critical increased serum level IL-33 in quiet experiencing allergic rhinitis. While another investigation showed more significant IL33-level of nasality discharges for house-dust bug touchy patient suffering from lasting hypersensitive rhinitis. The function of IL-33 in rhinitis was painted out in an investigation done by34 they demonstrated IL33 constitutive communicated of nasality epithelium cell delivered offer allergies introduction. Raised degree of IL33 was related with severity of AR symptoms, recommending the function of this cytokine in pathophysiology of this problem34,35.
IL-33 level was discovered to be firmly identified with allergic rhinitis seriousness in a study39 who discovered IL33 raised on serum from discontinuous hypersensitive rhinitis patient’s seriousness to grasses or trees dust as well connection of IL33 to malady severities recommend the IL33 associated with pathogenic of irregular allergic rhinitis. A study done by40 on patients with hypersensitive illness found that IL-33 was raised in quiet with asthma, rhinitis and urticaria when contrasted with controls.
IL33-IL1 receptors _like 1 (IL1RL1) path-ways polymorphism:
The elements for IL33 intervened among its receptors, the IL1RL1, IL1 receptors accessories proteins (IL1RAcP). Those receptors complicated triggered, among initiation of signal protein, arrival hypersensitive and eosinophils mediator, for example, IL5, IL13, bringing about eosinophilic-irritation then constriction for IL33 signal, This information showing the association between IL-33: IL1RL1 qualities on asthma organically plausibility41,42.
A late study demonstrated the outflow by IL33 associated with aviation route hyper-responsiveness, have guard, invulnerable guideline, aggravation, serum IgE rise and expanded eosinophil includes, on mice model, IL33 assumes basic functions at worsening IgE-interceded aviation route irritation and rebuilding, however, regardless of IL33 sera level correspond to asthma is right now obscure, that persuaded side on a current investigation. Genetically, there is a variety on each IL-33 and IL1RL1 unequivocally connected to asthma on genomic wide affiliation examines (GWAS) at Mexicans, Europeans, North-America, and the Brazilians populaces43.
Study44 proposed the IL1/RL1 singles nucleotides polymorphism (SNPs) may add to Mexican youth's asthma weakness. Other examination watched relationship among asthma and SNPs connected to IL1-RL1/IL18-R1 as well as IL-33 at the Europeans populace. IL33/IL1-RL1 local related to asthma danger on three racial gatherings on North-Americans populaces, yet study45 has repeated the relationship between IL-33 up-stream polymorphism and asthma, recently distinguished on dominatingly Europeans populace, at the autonomous Africans-Americans populace. IL-33, IL1-RL1 variations related to asthma at Brazilians populace, study46 discovered proof that hereditary variety of IL-33 and IL1-RL1 local converts to the expanded weakness of asthma. IL-33, IL1-R1 and RAD50 gene was additionally connected to the danger of asthma at Chinese populace.
IL33 applies the cytokines movement among the flagging receptors ST2, a dynamic-receptors complicated is contained IL33 bound ST2 and pervasively communicated, share a coreceptor named IL1R accessories proteins (AcPs), ST2 and AcPs enroll connector particles My D88 and IRAK to actuate enactment for transcriptional factors NF-kBas and MAP kinas, for example, p38, JNK Thus signaling instrument recognizes IL33 by old style T-helper-2 (Th2) cytokine, that sign among JAK–STAT pathway. ST2 expression dominatingly, however not solely, in immune-cells related to allergies irritation. ST2 mRNA is communicated constitutively by mature mast cells and mast cell forerunners heavily influenced by Th2-related GATA components.
Th2-yet not Th1-captivated T-cell likewise expressed ST2.researches by mice cells show the statement for ST2 in Th2 cell resulting at IL4 expressing as well as ST2 expressing in CD41 T-cells in-vivo restricts to Th2-overwhelmed resistant reaction on mucosal destinations. Efficiency of IL33 in those cells just like extra ST2-communicating human’s insusceptible cells summed up on accompanying areas Because of its capacity to drive conceivably unsafe tissue aggravation from numerous points of view, techniques have advanced for direct cytokines movement on IL33. The more notable system includes the confinement or balance in IL33 via ST2 solubility type (sST2) which communicated to fibroblast as well as different cells then emerges by means of a then again joined mRNA which is initiated by serum and other actuating boosts just as mitigating signs, for example, vitamin D.
sST2 goes about the distraction receptors for tie or viably restrain IL33 movement and the intensity to do so is expanding within sight of solubility co-receptors AcP. An extra type of guideline depicted including IL1 receptors family sing Ig/IL1 receptors correlated (SIGIRR) particle recently involved the negative controller on IL1, TLR flagging SIGIRR related to ST2 on cells and IL33 driven Th2 reactions are expanded each in-vitro and in-vivo to explores different avenues regarding SIGIRR lacking mouse. IL33 action subsequently theorized is adding to mucosal-inflammatory showed in SIGIRR-inadequate mice47.
Hereditary connections were made in asthma and allergies associated qualities or polymorphism on genes encoded IL33 as well as ST2 (IL-1/RL1) (Table1). Polymorphism at IL33gene (chromosome 9q) related on Japanese-cedar-pollinosis, more widely recognized type of hypersensitive rhinitis at Japan and asthma related IL-33 sing nucleotides polymorphism (SNP) distinguished on an investigation the roughly 2500 samples48, 49. The SNP at distally advertiser of IL1RL1-gene (chromosome 2q) is related to atopic dermatoses (AD) at little populace studies then a much more grounded affiliation find explicitly on AD patients with highly IgE level50. Similar polymorphisms were essentially connected to asthma at the populace in Australian-children giving intense side effects51. Additionally, youngsters homozygous of thus allele is higher illnesses severity levels than heterozygote or non-carriers52.
Useful correlation with polymorphisms was recognized via exhibiting AD-related ST2 advertiser variation intervened twofold transcription-action at humans pole cell contrasted and non-AD-related alleles. Thus it can bring about the carrier of the SNP having high measures of ST2 articulation in the effector’s cell; notwithstanding. Sickness related IL1/RL1 SNP is likewise distinguished to an investigation of Dutch asthma family. For such situation, a polymorphism was related to asthma just like IgE focuses or bronchial hyper responsiveness. Extra IL1/RL1 SNP was distinguished on an alternate report related, on the defensive way, by persistent rhinosinusitis Finally, in an enormous scope study intended to recognize arrangement variations adding to raised eosinophils number, IL-5, IL1/RL1 is 2 out of 5 qualities in SNP which arrived at genomes widely importance (IL-33 SNPs almost arrived at genomes wide centrality). Each of IL1/RL1 and IL-33 variations is likewise essentially connected to asthma at follow-on evaluation almost 8000 asthma patients and 45000 controls.
Hereditary connect to eosinophils number and asthma is significantly considered each of natural association among eosinophil and asthma just like the capacity of IL33 in straightforwardly advance eosinophils capacity then IL5 creation by numerous phones. Further investigation is needed to decide how extensively these individuals ailment related polymorphisms reproduce and whether practical connects can be recognized. Notwithstanding, hereditary commitments were to either ailment powerlessness or side effects by each of IL1/RL1 and IL-33 local on different investigations build up connection to a pathway itself. It suggests thus cytokines hubs are associated with human’s illness50.
Table 1: Polymorphism on ST2 (IL1/RL1) IL-33 correlated to allergies illness and asthma (116)
|
Locus |
SNP |
Association |
Location |
Effect |
Allele frequency (pop) |
|
ST2 (IL1RL1) |
rs6543116[A] |
Atopic dermatitis |
Promotor |
Not tested |
0.41 (Japanese) |
|
ST2 (IL1RL1) |
rs6543116[A] |
Childhood asthma |
Promotor |
Unknown |
0.44 (Australia) |
|
ST2 (IL1RL1) |
rs1420101[A] |
BHR |
Intron |
Unknown |
0.38 (Dutch asthma) |
|
ST2 (IL1RL1) |
rs1921622[A] |
BHR and asthma |
Intron |
Unknown |
0.64 (Dutch asthma) |
|
ST2 (IL1RL1) |
rs1861246[C] |
BHR and asthma |
Intron |
Unknown |
0.78 (Dutch asthma) |
|
ST2 (IL1RL1) |
rs1420101[A] |
Eosinophils and asthma |
Intron |
Unknown |
0.34-0.40 (several) |
|
ST2 (IL1RL1) |
several |
Chronic rhinosinusitis |
Various |
Unknown |
0.17-0.40 (Quebee) |
|
IL33 |
rs3939286[A] |
Eosinophils and asthma |
5’ of ATG |
Unknown |
0.04-0.29 (several) |
|
IL33 |
rs1929992[T] |
Allergic rhinitis |
Intron |
Unknown |
0.48 (Japanese) |
Genetics polymorphism identifies on ST2 (IL1/RL1) and IL-33 gene and its correlation to asthma or allergic related traits. SNPs refer to single-nucleotide-polymorphism identifying on the study and indicating the association alleles (A, G, C or T indicates to DNA-sequences at different positions). Alleles frequencies indicated to frequencies of trait and diseases association alleles at normal individuals studied51,53.
CONCLUSIONS:
In our investigation including the relationship of IL33 and IL1/RL1 genes polymorphism with sera IL33 level as well as the risks of respiratory hypersensitivity malady. we exhibited that the outflow sera IL33 related to asthma on members; rs-16924159A-A is related to highly IL33 level and the rs-16924159 G-A variation can influence a declaration of IL33 Further examinations expected in research causal connection with IL-33/IL1RL1 pathways genotype polymorphism IL33 level and Investigate IL-33/IL1RL1 pathways genotype polymorphism with IL33 level in patients with Coronavirus disease (COVID-19)
Ballesteros B. Tobias G. Shao L. Pellicer E. Nogués J. Mendoza E. Green ML et al Steam Purification for the Removal of Graphitic Shells Coating Catalytic Particles and the Shortening of Single‐Walled Carbon Nanotubes. Small. 2008; 4(9):1501-6.doi.org/10.1021/ja061680u
ACKNOWLEDGMENT:
The authors would like to thank Mustansiriyah University (www.uomustansiriyah.edu.iq) Baghdad-Iraq for its support in the present work.
REFERENCES:
1. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science. 2002; 296 (5567): 490-494. doi:0.1126/science.296.5567.490.
2. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008; 454(7203): 445-454. doi:10.1038/nature07204
3. Kaur, G., Singh, A., Narang, R. K., and Singh, G. Asthma: From Disease to Treatment-An Overview. International Journal of Bio-Pharma Research. 2020; 9(4): 2651-2560.http://dx.doi.org/10.21746/ijbpr.2020.9.4.1
4. Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clinical Immunology. 2018; 14(Suppl 2): 51. doi:10.1186/s13223-018-0280-7
5. Son JH, Park SY, Cho YS, Chung BY, Kim HO, Park CW. Immediate Hypersensitivity Reactions Induced by Triamcinolone in a Patient with Atopic Dermatitis. Journal of Korean Medical Sciences. 2018; 33(12): e87. doi: 10.3346/jkms.2018.33.e87.
6. Koike Y, Sato S, Yanagida N, Asaumi T, Ogura K, Ohtani K, Imai T, Ebisawa M. Predictors of Persistent Milk Allergy in Children: A Retrospective Cohort Study. International Achieves of Allergy and Immunology. 2018; 175(3): 177-180. doi: 10.1159/000486311.
7. Martin NT, Martin MU. Interleukin 33 is a guardian of barriers and a local alarmin. Nature Immunology. 2016; 17(2): 122-131. doi: 10.1038/ni.3370. PMID: 26784265.
8.
Cayrol C, Duval A, Schmitt P, Roga
S, Camus M, et al. Environmental allergens induce allergic inflammation through
proteolytic maturation of IL-33. Nature Immunology, 2018; 19(4): 375-385.
https://doi.org/10.1038/s41590-018-0067-5
9. Ding W, Zou GL, Zhang W, Lai XN, et al. Interleukin-33: its emerging role in allergic diseases. Molecules, 2018; 23(7): 1665. DOI:10.3390/molecules23071665
10. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. The Journal of Immunology. 2007; 179(4): 2551-2555. doi: 10.4049/jimmunol.179.4.2551.
11. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nature. Reviews Immunology, 2008; 8: 205-217.https://doi.org/10.1038/nri2273
12. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils and eosinophils. Journal Allergy Clinical immunology, 2010; 125(2 Suppl 2): S73-S80. doi:10.1016/j.jaci.2009.11.017
13. Yap JM, Ching MW, Cabanilla CQ, Ramos JD. Multiple house dust mite allergens sensitization profiles in children with allergic asthma. Journal of Allergy & Therapy, 2014; 5: 3. DOI:10.4172/2155-6121.1000179
14. Mansour AE, Yasein YA, Ghandour A, Zaidan O, Abo El-Abbas MM. Prevalence of bronchial asthma and its impact on the cognitive functions and academic achievement among preparatory school children in Egypt. The Journal of American Science, 2014; 10(7): 119-127.
15. Payrovee Z, Kashaninia Z, Rezasoltani P. Effect of family empowerment on the quality of life of school-aged children with asthma. Tanaffos, 2014; 13(1): 35-42.
16. Liu J, Shen JX, Hu LJ, Huang WH, Zhang GJ. Significance of interleukin -33 and its related cytokines in patient with breast cancer. Frontiers in Immunology, 2014; 5: 141.
17. Brightling CE, Gupta S, Gonem S, Siddiqui S. Lung damage and airway remodelling in severe asthma. Clinical and Experimental Allergy. 2012; 42(5): 638-649. doi: 10.1111/j.1365-2222.2011.03917.x.
18. Salujaa R, Ketelaarb ME, Hawroa T, et al. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Molecular Immunology, 2015; 63(1): 80-85. doi: 10.1016/j.molimm.2014.06.018.
19. Solarski B, Kurowski M, Kewin P, Xu D, Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. Journal Immunology, 2010; 185(6): 3472-3480. doi: 10.4049/jimmunol.1000730.
20. Lu J, Kang J, Zhang C, Zhang X. The role of IL-33/ST2L signals in immune cells. Immunology Letters, 2015; 164(1): 11-17. doi: 10.1016/j.imlet.2015.01.008.
21. Kreutzfeldt M, Hegazy AN, Schrick G, Fallon PG, Klemenz R. The alarmin interleukin-33 drives protective antiviral CD8+ T cell response. Science, 2012; 335(6071): 984-989. doi: 10.1038/nature13577.
22. Villarreal DO, Weiner.B. Interleukin-33: A switch-hitting cytokine. Current Opinion in Immunology, 2014; 28: 102-106. doi: 10.1016/j.coi.2014.03.004.
23. Herbert C, Bunting MM, Lambie N, Thomas PS, Kumar RK. Immunoreactivity for interleukin-33 in allergic airway inflammation. Journal Cytology & Histology, 2015; 6: 1. http://dx.doi.org/10.4172/2157-7099.1000302
24. Lamkanfi M, Dixit VM. IL-33 raises alarm. Immunity, 2009; 31(1): 5-7. doi: 10.1016/j.immuni.2009.06.011.
25. Makrinioti H, Toussaint M, Jackson DJ, Walton RP, Johnston SL. Role of IL-33 in respiratory allergy and asthma. The Lancet Respiratory Medicine, 2014; 2(3): 226-237. doi: 10.1016/S2213-2600(13)70261-3.
26. Farahani R, Sherkat R, Hakemi MG, Eskandari N, Yazdani R. Cytokine (interleukin-9, IL-17, IL-22, IL25 and IL-33) and asthma. Advanced Biomedical Research, 2014; 3: 127. doi:10.4103/2277-9175.133249
27. Liew FY, Pitman NI, Mcinnes IB. Disease-associated functions of IL-33: The new kid in the IL-1 family. Nature Reviews Immunology, 2010; 10: 103-110.
28. Borish L, Steinke JW. Interleukin -33 in asthma: How big of role does it play? Current Allergy and Asthma Reports, 2011; 11(1): 7-11.
29. Lioyd CM. IL-33-family members in asthma bringing innate and adaptive immune responses. Current Opinion in Immunology, 2010; 22(6): 800-806. doi: 10.1016/j.coi.2010.10.006.
30. Xu WD, Zhang M, Zhang YJ, Ye DQ. IL-33 in rheumatoid arthritis: Potential role in pathogenesis and therapy. Human Immunology, 2013; 74(9): 1057-1060. doi: 10.1016/j.humimm.2013.06.029.
31. Sattler S, Smits HH, Xu D, Huang FP. The evolutionary role of the IL-33/ST2 system in host immune defence. Archivum Immunologiae Therapiae Experimentalis, 2013; 61: 107-117. doi: 10.1007/s00005-012-0208-8.
32. Lloyd M. Allergy investigation: Major irritation or minor aggravation. In: Pathology Forum, 1st ed, 2014; 4: 6-8.
33. Sakashita M, Yoshimoto T, Hirota T, Harada M.; et al. Association of serum interleukin-22 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clinical Experimental Allergy, 2008; 38: 1875-1881. doi: 10.1111/j.1365-2222.2008.03114.x.
34. Haenuki Y, Matsushita K, Futatsugi S. A critical role of IL-33 in experimental allergic rhinitis. Journal Allergy Clinical Immunology, 2012; 130: 184-194. doi: 10.1016/j.jaci.2012.02.013.
35. Azizy EA, Elshora AE, Tantawy EA, Elsayd MA. Serum levels of interleukin-33 and its soluble receptor ST2 in asthmatic patients. Egyptian Journal of Chest Diseases and Tuberculosis, 2014; 63: 279-284. https://doi.org/10.1016/j.ejcdt.2013.11.005
36. Prefontaine D, Nadige J, Chouiali F, Audusseau S, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. Journal Allergy Clinical Immunology, 2010; 125: 752-754. doi: 10.1016/j.jaci.2009.12.935.
37. Guo Z, Wu J, Zhao J, Lin F, Chen Y, Bi L, et al. IL33 promotes airway remodeling and is a marker of asthma disease severity. Journal Asthma, 2014; 5: 1-7. doi: 10.3109/02770903.2014.921196.
38. Asaka D, Yoshikawa M, Nakayama T, Yoshimura T, et al. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis. International Archives of Allergy and Immunology, 2012; 158(Supp 1): 47-50. doi: 10.1159/000337764.
39. Gluck J, Rymanczyk B, Rogala B. Serum IL33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of disease severity. Inflammation Research Journal, 2012; 61(6): 547-550. doi: 10.1007/s00011-012-0443-9.
40. Ramdan MI, Candra P, K, Lusiana D, Duma K. Redesign of the Traditional Handloom for Sarong Female-Weavers Based on Anthropometric Data. 2020.
41. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?. PloS one, 2008; 3(10): e3331. doi: 10.1371/journal.pone.0003331.
42. Gao X, Chi, X., Wang, X., Wu, R., Xu, H., et al.IL-33 Inhibits Hepatitis B Virus through Its Receptor ST2 in Hydrodynamic HBV Mouse Model. Mediators of Inflammation, 2020.
43. Mizutani N, Nabe T, Yoshino S. Interleukin‐33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE‐mediated airway inflammation and remodelling in mice. Immunology, 2013; 139(2): 205-218. doi: 10.1111/imm.12071.
44. Kim S, Forno E, Yan Q, Jiang Y, et al. SNPs identified by GWAS affect asthma risk through DNA methylation and expression of cis-genes in airway epithelium. European Respiratory Journal, 2020; 55(4): 1902079. doi: 10.1183/13993003.02079-2019.
45. Queiroz GDA, Costa RDS, Alcantara‐Neves NM, et al. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population. International Journal of Immunogenetics, 2017; 44(2): 51-61. doi: 10.1111/iji.12306.
46. Chen J, Zhang J, Hu H, Jin Y, Xue M. Polymorphisms of RAD50, IL33 and IL1RL1 are associated with atopic asthma in Chinese population. Tissue Antigens, 2015; 86(6): 443-447. doi: 10.1111/tan.12688.
47. Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy, 2017; 2(1): 1-9. https://doi.org/10.1038/sigtrans.2017.23
48. Yuliwulandari R, Kashiwase K, Nakajima H, Uddin J, et al. Polymorphisms of HLA genes in Western Javanese (Indonesia): close affinities to Southeast Asian populations. Tissue Antigens, 2009; 73(1): 46-53. doi: 10.1111/j.1399-0039.2008.01178.x.
49. Baranzehi T, Karimi-Davani S, Kordi-Tamandani DM. Analysis of IL-33 Gene Polymorphisms (rs1157505C/G and rs11792633C/T) and the Risk of Tuberculosis in South[t45eastern Iran. Journal of Genetic Research. 2020; 6(1): 54-59. DOI: 10.22080/jgr.2020.17777.1166
50. Smith DE. IL‐33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clinical & Experimental Allergy, 2010; 40(2): 200-208. doi: 10.1111/j.1365-2222.2009.03384.x.
51. Hamzah IH, Ali Shafi FA, Noor Al-Huda AAHS. Study the Association of CYP3A5 Polymorphism on the Risk of Breast Cancer in Some of the Iraqi Women. Journal of Global Pharma Technology| 2018; 10(08):325-330
52. HamzahIH, Ali Shafi FA, Al Sharqi SAH, Brakhas SA. Cytology and molecular study for GSTP1 effect on asthma Iraqi patients. Clin Mol Allergy. 2019; 17: 4. https://doi.org/10.1186/s12948-019-0108-0
53. Saeed NAAA, Hamzah IH, Mohammed Ali AN, Abuderman ABA. Prediction of single nucleotide polymorphisms (SNPs) in apolipoprotein E gene and their possible associations with a deleterious effect on the structure and functional properties: an in silico approach. Network Modeling Analysis in Health Informatics and Bioinformatics. 2018; 7: 16. https://doi.org/10.1007/s13721-018-0178-9
Received on 23.05.2021 Modified on 05.07.2021
Accepted on 13.09.2021 © RJPT All right reserved
Research J. Pharm.and Tech 2022; 15(4):1768-1774.
DOI: 10.52711/0974-360X.2022.00296